Skip to content

Clinical trials

Metabolic Diseases trials in Argentina

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Diseases Country / region: Argentina Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20111
20151
20171
20181
20201
20222
20232
20245
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting4
Recruiting3
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company7
89bio, Inc.3
AstraZeneca1
Intellia Therapeutics1
Ionis Pharmaceuticals, Inc.1
Pfizer1
Shire1
Sumitomo Pharma Switzerland GmbH1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Diseases17
Diabetes Mellitus, Type 29
Glucose Metabolism Disorders8
Diabetes Mellitus7
Endocrine System Diseases7
Lipid Metabolism Disorders4
Genetic Diseases, Inborn3
Metabolism, Inborn Errors3
Body Weight2
Brain Diseases2

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.